B. Braun Melsungen AG Market Share Analysis

B. Braun Melsungen AG Market Share Analysis

Summary

Our new report, “B. Braun Melsungen AG Market Share Analysis” provides in-depth information on B. Braun’s market position in the different medical equipment markets it operates in. The report provides B. Braun’s market share information in nineteen key market categories – Neurosurgical Products, CSF Management, Hand Instruments, Syringes and Needles, Renal Dialysis Equipment, Disposable Hospital Supplies, Infusion Systems, Surgical Sutures, Rigid Endoscopes, Advanced Wound Management, Traditional Wound Management, Ostomy Drainage Bags, Compression Therapy, Incontinence Devices, Wound Closure Devices, Orthopedic Reamers, Insulin Delivery, Glucose Monitoring and Joint Reconstruction. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

Scope

- Global company shares (in Revenues) information for the key markets B. Braun operates in – Surgical Equipment, Hospital Supplies, Nephrology and Urology Devices, Wound Care Management, Neurology Devices, Drug Delivery Devices, Endoscopy Devices, Diabetes Care Devices and Orthopedic Devices.
- B. Braun’s company shares (in Revenues) information for all the key countries the company has presence in – United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- B. Braun’s company shares (in Revenues) information for all the key market categories the company has presence in – Neurosurgical Products, CSF Management, Hand Instruments, Syringes and Needles, Renal Dialysis Equipment, Disposable Hospital Supplies, Infusion Systems, Surgical Sutures, Rigid Endoscopes, Advanced Wound Management, Traditional Wound Management, Ostomy Drainage Bags, Compression Therapy, Incontinence Devices, Wound Closure Devices, Orthopedic Reamers, Insulin Delivery, Glucose Monitoring and Joint Reconstruction.
- All the key data-points are for 2009 and cover all the key regions – North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA) and South and Central America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any – Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, B. Braun operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to B. Braun’s market positions. SHOW LESS READ MORE >

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Surgical Equipment
3.1.1 Electrosurgical Devices
3.1.2 Hand Instruments
3.1.3 Surgical Sutures
3.2 Hospital Supplies
3.2.1 Disposable Hospital Supplies
3.2.2 Mobility Aids and Transportation Equipment
3.2.3 Patient Examination Devices
3.2.4 Sterilization and Disinfectant Equipment
3.2.5 Syringes and Needles
3.3 Nephrology and Urology Devices
3.3.1 Incontinence Devices
3.3.2 Lithotripters
3.3.3 Renal Dialysis Equipment
3.4 Wound Care Management
3.4.1 Advanced Wound Management
3.4.2 Automated Suturing Devices
3.4.3 Compression Therapy
3.4.4 Negative Pressure Wound Therapy (NPWT)
3.4.5 Ostomy Drainage Bags
3.4.6 Pressure Relief Devices
3.4.7 Traditional Wound Management
3.4.8 Wound Closure Devices
3.5 Neurology Devices
3.5.1 CSF Management
3.5.2 Interventional Neurology
3.5.3 Neurostimulation Devices
3.5.4 Neurosurgical Products
3.5.5 Radiosurgery
3.6 Drug Delivery Devices
3.6.1 Infusion Systems
3.6.2 Inhalation Systems
3.6.3 Needle Free Injections
3.7 Endoscopy Devices
3.7.1 Endoscopic Instruments
3.7.2 Endoscopic Reprocessors
3.7.3 Endoscopy Fluid Management Systems
3.7.4 Endoscopy Visualization Systems
3.7.5 Flexible Endoscopes
3.7.6 Rigid Endoscopes
3.8 Diabetes Care Devices
3.8.1 Glucose Monitoring
3.8.2 Insulin Delivery
3.9 Orthopedic Devices
3.9.1 Arthroscopy
3.9.2 Cranio Maxillofacial Fixation (CMF)
3.9.3 Joint Reconstruction
3.9.4 Orthobiologics
3.9.5 Orthopedic Accessories
3.9.6 Orthopedic Braces and Supports
3.9.7 Orthopedic Prosthetics
3.9.8 Orthopedic Reamers
3.9.9 Spinal Surgery
3.9.10 Trauma Fixation
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 SWOT Snapshot
5 Business Description
5.1 Business Overview
5.2 Aesculap division
5.2.1 Overview
5.2.2 Financials
5.2.3 Market View
5.2.4 Key Strategies
5.3 B. Braun Avitum division
5.3.1 Overview
5.3.2 Financials
5.3.3 Market View
5.3.4 Key Strategies
5.4 Hospital Care division
5.4.1 Overview
5.4.2 Financials
5.4.3 Market View
5.4.4 Key Strategies
5.5 Out Patient Market (OPM) division
5.5.1 Overview
5.5.2 Financials
5.5.3 Market View
5.5.4 Key Strategies
5.6 Major Products and Services
5.6.1 Overview
6 History
7 SWOT Analysis
7.1 Overview
7.2 B. Braun Melsungen AG Strengths
7.2.1 Significant Revenue Progress
7.2.2 Diversified Geographic Presence
7.2.3 Diversified Product and Services Portfolio
7.2.4 Industry Recognition
7.3 B. Braun Melsungen AG Weaknesses
7.3.1 Legal Proceedings
7.3.2 Decreasing Cash Positioning
7.3.3 Dependence on Suppliers
7.3.4 Product Recalls
7.4 B. Braun Melsungen AG Opportunities
7.4.1 New Product Launches
7.4.2 Strategic Agreements
7.4.3 Market Growth in Emerging Economies
7.4.4 Growing Aged Population
7.5 B. Braun Melsungen AG Threats
7.5.1 Intense Competition
7.5.2 Stringent Regulations
7.5.3 Cost Containment Pressures
7.5.4 Low-Cost Substitute Products in the Market
8 Competitors
9 Competitive Landscape
9.1 Hospital Supplies, Global, Market Share (%), 2009
9.2 Surgical Equipment, Global, Market Share (%), 2009
9.3 Nephrology and Urology Devices, Global, Market Share (%), 2009
9.4 Wound Care Management, Global, Market Share (%), 2009
9.5 Neurology Devices, Global, Market Share (%), 2009
9.6 Drug Delivery Devices, Global, Market Share (%), 2009
9.7 Endoscopy Devices, Global, Market Share (%), 2009
9.8 Diabetes Care Devices, Global, Market Share (%), 2009
9.9 Orthopedic Devices, Global, Market Share (%), 2009
10 B. Braun Melsungen AG Medical Equipment Market Share Analysis
10.1 B. Braun Melsungen AG, Global, Market Share (2009)
10.2 B. Braun Melsungen AG, Asia-Pacific, Market Share (2009)
10.2.1 B. Braun Melsungen AG, Australia, Market Share (2009)
10.2.2 B. Braun Melsungen AG, China, Market Share (2009)
10.2.3 B. Braun Melsungen AG, India, Market Share (2009)
10.2.4 B. Braun Melsungen AG, Japan, Market Share (2009)
10.2.5 B. Braun Melsungen AG, Other Asia-Pacific, Market Share (2009)
10.3 B. Braun Melsungen AG, Europe, Market Share (2009)
10.3.1 B. Braun Melsungen AG, France, Market Share (2009)
10.3.2 B. Braun Melsungen AG, Germany, Market Share (2009)
10.3.3 B. Braun Melsungen AG, Italy, Market Share (2009)
10.3.4 B. Braun Melsungen AG, Spain, Market Share (2009)
10.3.5 B. Braun Melsungen AG, United Kingdom, Market Share (2009)
10.3.6 B. Braun Melsungen AG, Other Europe, Market Share (2009)
10.4 B. Braun Melsungen AG, Middle East and Africa, Market Share (2009)
10.5 B. Braun Melsungen AG, North America, Market Share (2009)
10.5.1 B. Braun Melsungen AG, Canada, Market Share (2009)
10.5.2 B. Braun Melsungen AG, United States, Market Share (2009)
10.6 B. Braun Melsungen AG, South and Central America, Market Share (2009)
10.6.1 B. Braun Melsungen AG, Brazil, Market Share (2009)
10.6.2 B. Braun Melsungen AG, Other South and Central America, Market Share (2009)
11 B. Braun Melsungen AG Medical Equipment Market Share Analysis by Category
11.1 B. Braun Melsungen AG, Global, Category Revenue Share (2009)
11.2 B. Braun Melsungen AG, Asia-Pacific, Category Revenue Share (2009)
11.2.1 B. Braun Melsungen AG, Australia, Category Revenue Share (2009)
11.2.2 B. Braun Melsungen AG, China, Category Revenue Share (2009)
11.2.3 B. Braun Melsungen AG, India, Category Revenue Share (2009)
11.2.4 B. Braun Melsungen AG, Japan, Category Revenue Share (2009)
11.2.5 B. Braun Melsungen AG, Other Asia-Pacific, Category Revenue Share (2009)
11.3 B. Braun Melsungen AG, Europe, Category Revenue Share (2009)
11.3.1 B. Braun Melsungen AG, France, Category Revenue Share (2009)
11.3.2 B. Braun Melsungen AG, Germany, Category Revenue Share (2009)
11.3.3 B. Braun Melsungen AG, Italy, Category Revenue Share (2009)
11.3.4 B. Braun Melsungen AG, Spain, Category Revenue Share (2009)
11.3.5 B. Braun Melsungen AG, United Kingdom, Category Revenue Share (2009)
11.3.6 B. Braun Melsungen AG, Other Europe, Category Revenue Share (2009)
11.4 B. Braun Melsungen AG, Middle East and Africa, Category Revenue Share (2009)
11.5 B. Braun Melsungen AG, North America, Category Revenue Share (2009)
11.5.1 B. Braun Melsungen AG, Canada, Category Revenue Share (2009)
11.5.2 B. Braun Melsungen AG, United States, Category Revenue Share (2009)
11.6 B. Braun Melsungen AG, South and Central America, Category Revenue Share (2009)
11.6.1 B. Braun Melsungen AG, Brazil, Category Revenue Share (2009)
11.6.2 B. Braun Melsungen AG, Other South and Central America, Category Revenue Share (2009)
12 Key Employees
13 Company Statement
14 Locations And Subsidiaries
14.1 Head Office
14.2 Other Locations & Subsidiaries
15 Financial Deals Landscape
15.1 B. Braun Melsungen AG, Deals Volume Summary, 2005 to YTD 2010
16 B. Braun Melsungen AG Detailed Deal Summary
16.1 Partnerships
16.1.1 MEDRAD Enters Into Licensing Agreement with B. Braun Melsungen
16.1.2 B. Braun Enters Into Licensing Agreement With Chartie Hospital
16.1.3 B. Braun Signs An Agreement With Charite
16.1.4 Angiotech Pharmaceuticals Enters Into Distribution Agreement With B. Braun Melsungen
16.1.5 Specialized Health Products International Signs An Agreement With B. Braun Medical
16.1.6 B. Braun Melsungen Signs An Agreement With Nipro
16.2 Acquisition
16.2.1 Aesculap Completes Acquisition Of Remaining 50% Stake In INVITEC From Roeser Medical
16.2.2 B. Braun Medical Acquires Avitum
16.2.3 B. Braun Acquires Ascalon
16.2.4 B. Braun Acquires Saxonia Medical
17 Recent Developments
17.1 Strategy And Business Planning
17.1.1 Jun 16, 2010: B. Braun Opens Development Office
17.1.2 Sep 15, 2008: B. Braun Melsungen To Build A New Medical Production Facility In Hanoi, Vietnam
17.1.3 May 25, 2007: B. Braun Melsungen Enters Into Strategic Alliance With Health Robotics
17.1.4 Mar 24, 2007: B. Braun Melsungen To Shut Its Plant In Puerto Rico
17.1.5 Sep 19, 2005: B. Braun Medical Opens Manufacturing Facility In Suzhou
17.2 Financial Announcements
17.2.1 Mar 26, 2010: B. Braun Melsungen Reports Net Profit Of EUR 239.6 Million In 2009
17.2.2 Mar 24, 2009: B. Braun Melsungen Increases Sales By 6% To Reach EUR3.79 Billion For 2008 Fiscal Year
17.2.3 Mar 26, 2008: B. Braun Reports 2007 Results
17.2.4 Mar 28, 2007: B. Braun Melsungen Reports 2006 Results
17.3 Corporate Communications
17.3.1 Mar 26, 2010: B. Braun Appoints Dr. Hanns-Peter Knaebel As Board Member
17.3.2 Apr 01, 2009: B. Braun Melsungen Appoints Hanns-Peter Knaebel To Its Management Board
17.3.3 Dec 03, 2008: B. Braun Melsungen Appoints Deputy Member, Managing Board
17.4 Legal and Regulatory
17.4.1 Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter
17.4.2 Feb 11, 2010: Poly Medicure Gets Approval To Sell Safety IV Catheters In Germany
17.4.3 Feb 11, 2010: Düsseldorf Court Lifts Preliminary Injunctions Issued For B. Braun
17.4.4 Jan 10, 2010: Delhi High Court (HC) Rejects B Braun Melsungen's Petition Against Polymed
17.4.5 Jun 07, 2009: Poly Medicure Announces Appeal Decision In Patent Litigation With B. Braun
17.5 Product News
17.5.1 Apr 27, 2010: B. Braun’s Renal Therapy Division Launches Adimea In US
17.5.2 Mar 01, 2010: Heart Centre Rotenburg To Complete Phase II/III PEPCAD IV Clinical Study For SeQuent Please In Third Quarter Of 2011
17.5.3 Mar 01, 2010: University Of Ulm To Complete Phase II PEPCAD-CTO Study For SeQuent Please In Third Quarter Of 2014
17.5.4 Feb 25, 2010: Heart Centre Rotenburg To Complete Phase II/III PEPCAD V Trial For SeQuent Please In First Half Of 2011
17.5.5 Feb 22, 2010: Deutsches Herzzentrum Muenchen To Complete Phase IV ISAR-DESIRE-3 Trial For SeQuent Please In Third Quarter Of 2014
17.5.6 Feb 22, 2010: Klinikum Coburg To Complete PEPCAD DES Phase II Trial For SeQuent Please In First Half Of 2011
17.5.7 Nov 16, 2009: B. Braun Unveils PEPCAD III Study Results Of Coroflex DEBlue System At AHA Meeting
17.5.8 Aug 27, 2009: B. Braun To Complete The Phase III Trial For SeQuent Please In Second Quarter Of 2012
17.5.9 Mar 30, 2009: B. Braun’s SeQuent Please Receives CE Certification
17.5.10 Mar 31, 2008: Novel Balloon Catheter Appears Simpler, More Effective Than Drug-Eluting Stent
17.5.11 Mar 04, 2008: Acculan 3Ti Receive iF Product Design Award
17.5.12 Mar 04, 2008: OrthoPilot Receives iF Product Design Award
17.5.13 Oct 25, 2007: Early Results Of PEPCAD I And II Studies Demonstrates The Effectiveness And Safety Of The Drug-Eluting Balloon Over Drug-Eluting Stents
17.5.14 Jul 04, 2007: B. Braun Enrolls First Patient In PEPCAD III Study
17.5.15 Aug 24, 2004: Coroflex Please, A New Drug-Eluting Stent Enters Clinical Trial
17.6 Product Approvals
17.6.1 Mar 30, 2009: B. Braun’s SeQuent Please Receives CE Certification
17.7 Clinical Trials
17.7.1 Mar 01, 2010: Heart Centre Rotenburg To Complete Phase II/III PEPCAD IV Clinical Study For SeQuent Please In Third Quarter Of 2011
17.7.2 Mar 01, 2010: University Of Ulm To Complete Phase II PEPCAD-CTO Study For SeQuent Please In Third Quarter Of 2014
17.7.3 Feb 25, 2010: Heart Centre Rotenburg To Complete Phase II/III PEPCAD V Trial For SeQuent Please In First Half Of 2011
17.7.4 Feb 22, 2010: Klinikum Coburg To Complete PEPCAD DES Phase II Trial For SeQuent Please In First Half Of 2011
17.7.5 Feb 22, 2010: Deutsches Herzzentrum Muenchen To Complete Phase IV ISAR-DESIRE-3 Trial For SeQuent Please In Third Quarter Of 2014
17.7.6 Nov 16, 2009: B. Braun Unveils PEPCAD III Study Results Of Coroflex DEBlue System At AHA Meeting
17.7.7 Aug 27, 2009: B. Braun To Complete The Phase III Trial For SeQuent Please In Second Quarter Of 2012
17.7.8 Mar 31, 2008: Novel Balloon Catheter Appears Simpler, More Effective Than Drug-Eluting Stent
17.7.9 Oct 25, 2007: Early Results Of PEPCAD I And II Studies Demonstrates The Effectiveness And Safety Of The Drug-Eluting Balloon Over Drug-Eluting Stents
17.7.10 Jul 04, 2007: B. Braun Enrolls First Patient In PEPCAD III Study
17.7.11 Aug 24, 2004: Coroflex Please, A New Drug-Eluting Stent Enters Clinical Trial
17.8 Other Significant Developments
17.8.1 Jan 06, 2010: B. Braun To Invest Another EUR1.6 Billions
17.8.2 Jan 06, 2010: B. Braun Adopts New Worldwide Investment Program
17.8.3 May 27, 2009: B. Braun Selects Honeywell To Provide Process Control Solutions For Plant In Melsungen, Germany
17.8.4 Apr 29, 2009: B. Braun Melsungen Invests EUR82 Million In Medical Device Production Facility
17.8.5 Mar 24, 2009: I-Flow Signs LoI with B. Braun Melsungen For International Distribution Of ON-Q Products
17.8.6 Jul 08, 2008: B. Braun Melsungen Invests EUR16 Million In India
17.8.7 Oct 25, 2007: B. Braun Melsungen Signs Distribution Agreement With NIPRO
17.8.8 Mar 15, 2007: B. Braun Melsungen To Invest In Medical Technology Production
18 Appendix
18.1 Research Methodology
18.2 Secondary Research
18.3 Primary Research
18.4 Models
18.5 Forecasts
18.6 Expert Panels
18.7 Consulting
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer

3M Health Care
Abbott Laboratories
Accuray Incorporated
Advanced Medical Solutions Group Plc
Advanced Sterilization Products Services Inc.
ALCARE Co., Ltd.
AlloSource
Animas Corporation
Ansell Limited
Antares Pharma, Inc.
ApaTech Limited
Apex Biotechnology Corp
ARKRAY, Inc.
Arthrex, Inc.
ArthroCare Corporation
Asahi Kasei Medical Co., Ltd.
Astra Tech Inc.
AstraZeneca International plc
Australian Biotechnologies
B. Braun Melsungen AG
BASKO HEALTHCARE
Bauerfeind AG
Baxter International Inc.
Bayer HealthCare AG
Becton, Dickinson and Company
Beijing Libeier
Bioject Medical Technologies Inc.
Biomet, Inc.
Biopol Co., Ltd.
Biotek
BlueSky Medical Group, Inc.
Boehringer Ingelheim GmbH
Bonovo Orthopedics, Inc.
Boss Instruments, Ltd.
Boston Scientific Corporation
Bovie Medical Corporation
BSN medical GmbH
C. R. Bard, Inc.
Cardinal Health, Inc.
CareFusion Corporation
Casex Industria de Plasticos e Produtos Medicos Ho
CENTENIAL SURGICAL SUTURE LTD.
Codman & Shurtleff, Inc.
Coloplast A/S
CONMED Corporation
ConvaTec
Cordis Corporation
Corentec Co., Ltd.
Corin Group PLC
Covidien plc
Custom Ultrasonics Incorporated
Cyberonics, Inc.
Daiken Medical Co., Ltd.
DePuy, Inc.
Derma Sciences, Inc.
DeRoyal Industries
DJO Incorporated
Dornier MedTech GmbH
Dynek Pty. Ltd.
Elekta AB
Eli Lilly and Company
Encore Medical Corporation
Endolite India Limited
ERBE Elektromedizin GmbH
Ethicon, Inc.
ev3 Inc.
Exactech, Inc.
F. Hoffmann-La Roche Ltd.
Feuerstein GmbH
Forecreu SA
Fresenius Medical Care AG & Co. KGaA
FUJIFILM Holdings Corporation
Fujinon Corporation
Gambro AB
Genzyme Corporation
Getinge AB
Given Imaging Ltd.
GlaxoSmithKline plc
Globus Medical, Inc.
Hanger Orthopedic Group, Inc.
Hangzhou Tonglu Sophisticated Endoscopes Co., Ltd.
Hartmann Group
HealthTronics, Inc.
Hill-Rom, Inc.
Hollister Incorporated
Hospira, Inc.
HOYA Corporation
Huntleigh Healthcare Ltd
IGROBE Rodar SL
IMECO S.A.
Innothera
INOR Orthopaedics
Integra LifeSciences Holdings Corporation
IntroMedic
Invacare Corporation
Japan Medical Materials Corporation
JMS CO., LTD.
Johnson & Johnson
Kanghui Medical Innovation Co., Ltd.
KARL STORZ GmbH & Co. KG
Karomed
Kimberly-Clark Corporation
Kinetic Concepts, Inc.
KLS Martin L.P.
Korea Bone Bank Inc.
Laboratoires Urgo
LifeScan, Inc.
Lohmann & Rauscher GmbH & Co. KG
Lotus Surgicals Pvt. Ltd.
MANMAN
MCo HOSPITAL AIDS PVT. LTD.
Medartis AG
MEDICON eG
Medline Industries, Inc.
Medtronic, Inc.
Micrus Endovascular Corporation
MILLENNIUM SURGICAL CORP.
Minntech Corporation
Molnlycke Health Care AB
NIKKISO CO., LTD.
NIPRO CORPORATION
Noble Biomaterials Europe srl
Novartis Medical Nutrition
Novo Nordisk A/S
NuVasive, Inc.
NxStage Medical, Inc.
Nycomed International Management GmbH
Olympus Medical Systems Corp.
Ontex N.V.
Orthofix International N.V.
Orthovita, Inc.
Ossur hf.
OsteoMed
Osteotech, Inc.
Otto Bock HealthCare GmbH
Pentax Corporation
Peters Surgical
Plenum Technologies Private Limited
Regeneration Technologies, Inc.
Resorba GmbH
Richard Wolf Gmbh Endoskope
S. H. PITKAR ORTHOTOOLS PVT. LTD.
Sanofi-Aventis
Scanlan International, Inc.
Schiller Healthcare India Pvt. Ltd.
Sepracor Inc.
Shanghai Huger Endoscopy Instruments Co., Ltd.
Siemens Healthcare
Sklar Instruments
Smith & Nephew Plc
Smiths Medical
Solco Biomedical Co., Ltd.
Sorin Group
Spectrum Surgical Instruments Corporation
SSM Sterile Health Products Inc.
St. Jude Medical, Inc.
Stericat Gutstrings Pvt. Ltd.
STERIS Corporation
Storz Medical AG
Stryker Corporation
SUSHRUT SURGICALS PRIVATE LIMTED
Sutures India Private Limited
Suzhou Xinrong Best Medical Instrument Co., Ltd.
Svenska Celulosa Aktiebolaget SCA
Synergetics USA, Inc.
Synthes, Inc.
Systagenix Wound Management
Taeyeon Medical CO.,LTD
Teleflex Incorporated
Terumo Corporation
Thuasne Cr, S.R.O.
THUASNE SA
Top Corp.
Trauson Holdings Company Limited
Trimox
Trivitron Group of Companies
U&I Corporation
Uma Surgicals
Unicharm Corporation
Vissco Rehabilitation Aids Pvt. Ltd
Vital Biosystems Pvt. Ltd.
VYGON Neuro
WRIGHT MEDICAL GROUP, INC.
Zhejiang Loen Endotech Co., Ltd.
Zimmer Holdings, Inc.